2025-11-12T18:35:32-08:00 2024-12-31 371420474 Fontanello Duffield & Otake LLP 111 Pine Street Suite 1750 San Francisco CA 94111 990 2024-01-01 930988840 National Eczema Association NATI 4154993474 505 San Marin Drive B300 Novato CA 94945 Kristin Belleson CEO 2025-11-12 true true Erik Satow P01410341 4159830200 2024 2025-03-06 01:10:19Z Kristin Belleson 12958720 false X www.nationaleczema.org X 1988 CA NEA is the driving force for an eczema community fueled by knowledge, strengthened through collective action and propelled by the promise of a better future. 9 9 31 450 875947 3748923 5393885 3635456 3850659 -173298 912839 1045 16430 7212126 10173813 616101 688173 0 4373497 4812531 0 1141206 3132931 4249322 8122529 9750026 -910403 423787 8910198 9360729 397879 551438 8512319 8809291 NEA is the driving force for an eczema community fueled by knowledge, strengthened through collective action and propelled by the promise of a better future. false false 6683095 3850659 Eczema Research, Awareness & Patient SupportThe National Eczema Association (NEA) improves the quality of life for people affected by eczema through research, education, advocacy, and community support. In 2024, NEA conducted its second national burden survey focused on forms of eczema beyond atopic dermatitis to guide care and research priorities. NEA hosted Eczema Expo 2024 in Denver with 400+ participants, providing education, connection, and mental-health resources92% reported feeling more supported. The EczemaWise mobile app surpassed 25,000 users and received multiple national awards for patient engagement. The Seal of Acceptance grew to 525+ products and expanded into lip care, deodorant, and apparel categories. NEA Ambassadors led 250+ advocacy actions, advancing the Safe Step Act and HELP Copays Act. NEAs #EczemaEverywhere campaign during Eczema Awareness Month 2024 reached 7 million impressions, amplifying public understanding of eczema as a serious disease. 688173 688173 Eczema Research We FundNEA celebrated 21 years of research investment by awarding nearly $1 million in 2024 to scientists studying eczema biology, inflammation, and psychosocial impact. Funded projects examined new therapeutic pathways, itch mechanisms, and barrier-repair science. Since its inception, NEA has awarded over $7 million to research advancing diagnosis, treatment, and patient outcomes.Community & Global EngagementNEA expanded its leadership role through the Global Skin Alliance and international eczema collaborations in Prague and Melbourne, sharing research and policy solutions worldwide. NEA strengthened clinician partnerships through its Healthcare Provider Collaborative and expanded digital education for patients and caregivers. NEAs digital and social channels now reach hundreds of thousands annually, providing trusted information and connection across the eczema community. 7371268 true true false false false false false false false false true false false false true true true false false false true true false false false false false true true true false false false false false false false false false false false false false false false false false true 77 0 true 31 true true true false false false false false false 0 false false false false false false false X 9 9 false false false false false false false true true false false true true true true true true true false false AK AR AZ CA CT FL GA IL KS KY LA MD ME MI MN MO MS NC NH NY OH OR PA RI SC UT VA WA WI WV X X X Kristin Belleson 4154993474 505 San Marin Drive Ste B300 Novato CA 94945 X Wendy Smith Begolka Chief Strategy Off 40.00 0.00 249036 0 37356 Julie Bock til 72024 CEO 40.00 0.00 224519 0 33678 Melody Sugg VP, Philanthropy 40.00 0.00 199000 0 29850 Amber Favetti VP Mkting & Comms 40.00 0.00 196800 0 29520 Kristin Belleson CEO 40.00 0.00 199830 0 0 Amy Chrnelich Secretary/Dir 2.00 0.00 X X 0 0 0 Mike Bristol Treas/CFO/Dir 2.00 0.00 X 0 0 0 Sarah Young O'Donnell Chairman/Dir 2.00 0.00 X X 0 0 0 Scott Sanford COO 40.00 0.00 0 0 0 1069185 130404 19 false true false 0 5393885 5393885 Patient Forums 887261 887261 Publications 875947 875947 Seal of Acceptance 2087451 2087451 3850659 126503 126503 0 0 0 3571243 2784907 786336 786336 786336 126 126 0 0 Other Income 900099 12436 12436 Returned Grant 900099 3868 3868 16304 10173813 2991016 875947 912839 X 292494 292494 152557 152557 243122 243122 0 0 0 3794204 2716345 473075 604784 0 735158 531333 84180 119645 283169 200990 38472 43707 27235 27235 17669 13424 3420 825 112279 85302 21736 5241 0 0 0 1530355 1162659 296259 71437 235253 223680 3530 8043 170031 92520 15588 61923 262425 199372 50803 12250 0 141908 101500 17809 22599 211165 108168 74449 28548 0 0 0 0 488532 488532 25092 17964 3128 4000 Program & Awareness Events 336562 320005 5050 11507 Taxes, Licenses & Fees 296689 212406 36992 47291 Conference/Event Exhibition 118252 112435 1774 4043 Bad Debt Expense 79552 79552 196323 96460 84052 15811 9750026 7371268 1237552 1141206 1407818 857944 0 0 631090 1551886 0 0 0 0 68 139359 125768 254703 125768 4971923 5529708 0 0 1632996 1144464 11600 11600 8910198 9360729 71748 172797 50000 240000 276131 138641 397879 551438 X 8352599 8566107 159720 243184 8512319 8809291 8910198 9360729 423787 -132315 5500 X false true X true false X 3553306 3688366 4151638 3748923 5393885 20536118 0 0 3553306 3688366 4151638 3748923 5393885 20536118 6139700 14396418 83941 77024 146022 144137 126503 577627 0 0 21113745 0.68190 0.60800 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 125768 125768 125768 Lease Obligation - Current 138641 138641 X 10173813 10173813 10173813 9750026 9750026 9750026 Part X : FIN48 Footnote The Organization adopted the recognition requirements for uncertain income tax positions as required by generally accepted accounting principles, with no cumulative effect adjustment required. Income taxbenefits are recognized for income tax positions taken or expected to be taken in a tax return, only when it is determined that the income tax position will more-likely-than-not be sustained upon examination by taxing authorities. The Organization has analyzed tax positions taken for filing with the Internal Revenue Service and all state jurisdictions where it operates. The Organization believes that income tax filing positions will be sustained upon examination and does not anticipate any adjustments that would result in a material adverse effect on the Organizations financial condition, results of operations or cash flows. Accordingly, the Organization has not recorded any reserves, or relatedaccruals for interest and penalties for uncertain income tax positions at December 31, 2024. The Organization is subject to routine audits by taxing jurisdictions; however, there are currently no auditsfor any tax periods in progress. true North America 0 0 Research Grant Research Grant 63122 Europe 0 0 Research Grant Research Grant 50000 Middle East 0 0 Research Grant Research Grant 50000 East Asia and Pacific 0 0 Research Grant Research Grant 25000 Europe 0 0 Research Grant Research Grant 55000 243122 243122 East Asia & Pac Research 25000 Wire Europe Research 25000 Wire Europe Research 25000 Wire Europe Research 5000 Wire Europe Research 50000 Wire Middle East Research 50000 Wire North America Research 5625 Wire North America Research 57497 Wire 1 7 false false false false false false Part I, Line 2 - Grantmakers Explanation For Monitoring Use of Funds Outside US Grants are awarded based upon recommendations of independent peer review committee which evaluates responses to requests for proposals. A portion of grant award is paid when contract is signed. Final payment is not made until peer review committee approves final report. true Boston Childrens Hospital 300 Longwood Ave Boston MA 02115 042774441 50000 0 Research Childrens Hospital of Philly 3401 Civic Center Blvd Philadelphia PA 19104 231352166 501(c)(3) 12550 0 Research Emory University 201 Dowman Drive Atlanta GA 30322 580566256 30000 0 Research Harvard College 1033 Massachusetts Avenue Cambridge MA 02138 042103580 501(c)(3) 25000 0 Research John Hopkins Wilmer Eye Inst 1800 Orleans St Baltimore MD 21287 521118420 16668 0 Research UC San Diego 9500 Gilman Dr La Jolla CA 92093 956006144 19987 0 Research UC San Francisco 505 Parnassus Ave San Francisco CA 94143 946036493 80000 0 Research Univ Pennsylvania 3400 Civic Center Blvd Philadelphia PA 19104 231352685 15000 0 Research University of Texas 110 Inner Campus Drive Austin TX 78705 746000203 8327 0 Research Yale University 149 Elm Street New Haven CT 06511 060646973 501(c)(3) 25000 0 Research 10 0 Scholarships 54 39977 N/A Honorariums 140 112580 N/A Research Grant 1 N/A Grantmaker's Description of How Grants are Used Grants are awarded based upon recommendations of independent scientific advisory committee which evaluates responses to request for proposal. One third of the grants are paid when contract is signed, one third upon submission of six month progress report, and the remainder paid upon submission of final report. true X X X false false false false false false false false false Amber Favetti VP Mkting & Comms 196800 29520 226320 Julie Bock til 72024 CEO 224519 33678 258197 Kristin Belleson CEO 199830 199830 Melody Sugg VP, Philanthropy 199000 29850 228850 Wendy Smith Begolka Chief Strategy Off 249036 37356 286392 Form 990, Part VI, Section B, Line 11b Form 990 is reviewed by directors at meeting scheduled for that purpose, return preparer is available to explain form and answer questions. Form 990, Part VI, Section B, Line 12c Officers and directors complete an annual disclosure statement. Form 990, Part VI, Section B, Line 15a Compensation is determined by reference to performance and comparable organizations based on data published by the National Health Council. Form 990, Part VI, Section C, Line 19 Available upon request.